Langmead CJ - Search Results

1

Molecular insights into orphan G protein-coupled receptors relevant to schizophrenia.

Lu Y, Hatzipantelis CJ, Langmead CJ, Stewart GD. Lu Y, et al. Among authors: langmead cj. Br J Pharmacol. 2023 Aug 22. doi: 10.1111/bph.16221. Online ahead of print. Br J Pharmacol. 2023. PMID: 37605621 Review.

2

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA. Hughes ZA, et al. Among authors: langmead cj. Eur J Pharmacol. 2005 Mar 7;510(1-2):49-57. doi: 10.1016/j.ejphar.2005.01.018. Eur J Pharmacol. 2005. PMID: 15740724

3

Evaluation of expression and function of the H+/myo-inositol transporter HMIT.

Di Daniel E, Mok MH, Mead E, Mutinelli C, Zambello E, Caberlotto LL, Pell TJ, Langmead CJ, Shah AJ, Duddy G, Kew JN, Maycox PR. Di Daniel E, et al. Among authors: langmead cj. BMC Cell Biol. 2009 Jul 16;10:54. doi: 10.1186/1471-2121-10-54. BMC Cell Biol. 2009. PMID: 19607714 Free PMC article.

4

Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands.

Goodwin JA, Hulme EC, Langmead CJ, Tehan BG. Goodwin JA, et al. Among authors: langmead cj. Mol Pharmacol. 2007 Dec;72(6):1484-96. doi: 10.1124/mol.107.038265. Epub 2007 Sep 11. Mol Pharmacol. 2007. PMID: 17848601

5

SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.

Scott C, Langmead CJ, Clarke KL, Wyman P, Smith PW, Starr KR, Dawson LA, Price GW, Hagan JJ, Watson J. Scott C, et al. Among authors: langmead cj. Neuropharmacology. 2006 Jun;50(8):984-90. doi: 10.1016/j.neuropharm.2006.01.008. Epub 2006 Mar 20. Neuropharmacology. 2006. PMID: 16546225

6

G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.

Thomas RL, Mistry R, Langmead CJ, Wood MD, Challiss RA. Thomas RL, et al. Among authors: langmead cj. J Pharmacol Exp Ther. 2008 Nov;327(2):365-74. doi: 10.1124/jpet.108.141788. Epub 2008 Jul 29. J Pharmacol Exp Ther. 2008. PMID: 18664591 Free article.

7

Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors.

Lebon G, Langmead CJ, Tehan BG, Hulme EC. Lebon G, et al. Among authors: langmead cj. Mol Pharmacol. 2009 Feb;75(2):331-41. doi: 10.1124/mol.108.050963. Epub 2008 Nov 11. Mol Pharmacol. 2009. PMID: 19001633 Free PMC article.

8

Screening for positive allosteric modulators: assessment of modulator concentration-response curves as a screening paradigm.

Langmead CJ. Langmead CJ. J Biomol Screen. 2007 Aug;12(5):668-76. doi: 10.1177/1087057107301854. Epub 2007 May 3. J Biomol Screen. 2007. PMID: 17478477

9

Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.

Thomas RL, Langmead CJ, Wood MD, Challiss RA. Thomas RL, et al. Among authors: langmead cj. J Pharmacol Exp Ther. 2009 Dec;331(3):1086-95. doi: 10.1124/jpet.109.160242. Epub 2009 Sep 18. J Pharmacol Exp Ther. 2009. PMID: 19767446 Free PMC article.

10

Neurochemical changes in LPA1 receptor deficient mice--a putative model of schizophrenia.

Roberts C, Winter P, Shilliam CS, Hughes ZA, Langmead C, Maycox PR, Dawson LA. Roberts C, et al. Neurochem Res. 2005 Mar;30(3):371-7. doi: 10.1007/s11064-005-2611-6. Neurochem Res. 2005. PMID: 16018581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page